Mayo Clinic ProceedingsVirmani R, Forman MB, eds. Nonatherosclerotic Ischemic Heart Disease. New York, NY: Raven Press; 1989:1-428.Virmani R, Rogan K, Cheitlin MD: Congenital coronary artery anomalies: Pathologic aspects. In Virmani R, Forman MB (eds) (1989) Nonatherosclerotic Ischemic ...
Mayo Clinic College of Medicine, Rochester, MNCynthia S. CrowsonMayo Clinic College of Medicine, Rochester, MNJohn Wiley & Sons, LtdArthritis & RheumatismGabriel SE, Crowson CS. Ischemic heart disease and rheumatoid arthritis: comment on the article by Holmqvist et al. Arthritis & Rheumatism ...
ischemic heart disease局部缺血性心脏病 ischemic necrosis缺血性坏死 ischemic cardiomyopathy缺血性心肌病 ischemic_医学行业词汇 局部缺血的 ischemic词源英文解释 New Latin ischaemia, from ischaemus styptic, from Greek ischaimos, from ischein to restrain (akin to Greek echein to hold) + haima blood — ...
Homocysteine Level and Coronary Heart Disease Incidence: A Systematic Review and Me-ta-analysis. Mayo Clin. Proc. 2008, 83, 1203–1212. [Google Scholar] [CrossRef] Milani, R.V.; Lavie, C.J. Homocysteine: The Rubik’s Cube of Cardiovascular Risk Factors. Mayo Clin. Proc. 2008, 83, ...
Atherosclerotic vascular disease is the leading cause of ischemic stroke, resulting in occlusive or severely stenotic lesions of major intracranial or extr... HPA Jr - 《Mayo Clinic Proceedings》 被引量: 168发表: 2009年 Heparin in acute ischemic stroke: the case for a new clinical trial. More...
Springer Semantic Scholar dx.doi.org ResearchGate mayoclinic.pure.elsevier.com 相似文献 参考文献 引证文献Stem cell therapy for ischemic heart disease. Stem cell transplantation has emerged as a novel treatment option for ischemic heart disease. Different cell types have been utilized and the recent de...
Dr Widmer: Great. Thanks, Dr Suri, those great insights. Thanks to our viewers, and we hope you continue to check out future content on Mayo Clinic's page ontheheart.orgon Medscape.
Despite multimodal regimens and diverse treatment options alleviating disease symptoms, morbidity and mortality associated with advanced ischemic heart failure remain high. Recently, technological innovation has led to the development of regenerative the
TIAs can now stand on their own as an important, and, at times, unique aspect of symptomatic cerebrovascular disease, distinct enough to warrant a textbook in its own right. With new information on a worrisome and serious natural history, growing knowledge of risk factors and their management,...
(median age, 70 years [IQR, 58-81 years]) and had a higher prevalence of coexistent medical conditions, such as atrial fibrillation or flutter, coronary artery disease or prior myocardial infarction, hypertension, heart failure, and prior stroke (Table 1; all absolute standardized differences >...